Archived Clinical Summary
Colorectal Cancer: Screening
Originally published on: January 13, 2014
This recommendation statement is currently archived and inactive. It should be used for historical purposes only. Click here for copyright and source information .
Disclaimer:Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Archived: Clinical Summary of U.S. Preventive Services Task Force
This document is a summary of the 2008 recommendation of the U.S. Preventive Services Task Force (USPSTF) on screening for colorectal cancer. This summary is intended for use by primary care clinicians.
Select for copyright and source information.
|Population||Adults Age 50 to 75*||Adults Age 76 to 85 years*||Adults Older than 85*|
|Recommendation||Screen with high sensitivity fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy.
|Do not screen routinely
|Do not screen
For all populations, evidence is insufficient to assess the benefits and harms of screening with computerized tomography colonography (CTC) and fecal DNA testing.
High sensitivity FOBT, sigmoidoscopy with FOBT, and colonoscopy are effective in decreasing colorectal cancer mortality.
|Screening Test Intervals||
Intervals for recommended screening strategies:
|Balance of Harms and Benefits||
The benefits of screening outweigh the potential harms for 50- to 75-year-olds.
The likelihood that detection and early intervention will yield a mortality benefit declines after age 75 because of the long average time between adenoma development and cancer diagnosis.
Focus on strategies that maximize the number of individuals who get screened.
|Relevant USPSTF Recommendations||
*These recommendations do not apply to individuals with specific inherited syndromes (Lynch Syndrome or Familial Adenomatous Polyposis) or those with inflammatory bowel disease.
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents please go to http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Internet Citation: Clinical Summary: Colorectal Cancer: Screening. U.S. Preventive Services Task Force. October 2008.